on 25 Apr 2023
Last Applicant/ Owned by
10835 ROAD TO THE CURE, SUITE 205
SAN DIEGO
CA
92121
Serial Number
88718646 filed on 06th Dec 2019
Registration Number
7037414 registered on 25th Apr 2023
Correspondent Address
Ian W. Gillies
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Drug discovery services; pharmaceutical research and development Chemical, biochemical and biotechnological preparations used in industry and science, and in the manufacture of pharmaceuticals, pharmaceutical preparations and substances, that are used for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases Pharmaceuticals, pharmaceutical preparations and substan Read More
Drug discovery services; pharmaceutical research and development
12th Oct 2022
12th Oct 2022
Pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases
12th Oct 2022
12th Oct 2022
Chemical, biochemical and biotechnological preparations used in industry and science, and in the manufacture of pharmaceuticals, pharmaceutical preparations and substances, that are used for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases
05th Oct 2021
05th Oct 2021
No 88718646
No Service Mark
No ZENO.070T
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
25th Apr 2023 | REGISTERED-PRINCIPAL REGISTER |
25th Apr 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
21st Mar 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
18th Mar 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
02th Mar 2023 | STATEMENT OF USE PROCESSING COMPLETE |
01st Mar 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
09th Feb 2023 | USE AMENDMENT FILED |
09th Feb 2023 | TEAS STATEMENT OF USE RECEIVED |
17th Nov 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
15th Nov 2022 | SOU EXTENSION 4 GRANTED |